Millrace Asset Group’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.7M Buy
231,322
+27,084
+13% +$193K 1.72% 24
2024
Q2
$1.34M Buy
204,238
+86,949
+74% +$655K 1.3% 40
2024
Q1
$1.11M Sell
117,289
-68,390
-37% -$586K 1.11% 51
2023
Q4
$1.46M Buy
+185,679
New +$1.35M 1.44% 38
2021
Q3
Sell
-30,093
Closed -$215K 80
2021
Q2
$215K Sell
30,093
-208,816
-87% -$1.81M 0.11% 82
2021
Q1
$2.42M Buy
238,909
+49,183
+26% +$463K 1.3% 37
2020
Q4
$1.47M Buy
189,726
+93,893
+98% +$826K 1.02% 54
2020
Q3
$828K Buy
95,833
+74,349
+346% +$750K 0.67% 68
2020
Q2
$206K Sell
21,484
-191,957
-90% -$1.49M 0.21% 72
2020
Q1
$1.02M Buy
+213,441
New +$1.06M 1.53% 35

Other funds holding VMD

Millrace Asset Group's VMD Position: Q3 2024 in Review

Millrace Asset Group increased its Viemed Healthcare (VMD) stake by 13% in Q3 2024, buying an estimated $193K and bringing the position to 231,322 shares worth $1.7M. The position accounts for 1.72% of the portfolio, ranked #24.

Millrace Asset Group first reported a position in VMD in Q1 2020 and has held it in 10 quarters since. The position peaked at $2.42M in Q1 2021. 121 funds tracked by Wall St. Rank hold VMD as of Q3 2024.

  • Millrace Asset Group held 231,322 shares of Viemed Healthcare worth $1.7M as of Q3 2024.
  • Millrace Asset Group bought 27,084 Viemed Healthcare shares in Q3 2024, an estimated $193K.
  • Viemed Healthcare made up 1.72% of Millrace Asset Group's portfolio in Q3 2024, its #24 holding.
  • Millrace Asset Group first reported a position in Viemed Healthcare in Q1 2020 and has held it in 10 quarters since.
  • Millrace Asset Group's Viemed Healthcare position peaked at $2.42M in Q1 2021.
  • 121 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.